Quantification of antigen specific CD8+ T cells using an ELISPOT assay-Reference-Cited by-同舟云学术

Quantification of antigen specific CD8+ T cells using an ELISPOT assay

Published:1995-04 Issue:1 Volume:181 Page:45-54
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Miyahira Yasushi,Murata Kenichiro,Rodriguez Dolores,Rodriguez Juan R.,Esteban Mariano,Rodrigues Mauricio M.,Zavala Fidel

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference12 articles.

1. Phenotypic analysis of the inflammatory exudate in murine lymphocytic choriomeningitis;Ceredig;J. Exp. Med.,1987

2. Quantitation of human influenza virus-specific cytotoxic T lymphocytes: correlation of cytotoxicity and increased numbers of IFN-γ producing CD8+ T cells;Di Fabio;Int. Immunol.,1994

3. Selected Methods in Cellular Immunology;Grabstein,1980

4. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria;Li,1993

5. Precursor cells specific to sheep red cells in nude mice. Estimation of frequency in the microculture system;Quintans;Eur. J. Immunol.,1973

Cited by 314 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACE configurator for ELISpot: optimizing combinatorial design of pooled ELISpot assays with an epitope similarity model;Briefings in Bioinformatics;2023-11-22

2. ACE Configurator for ELISpot (ACE): Optimizing Combinatorial Design of Pooled ELISpot Assays with an Epitope Similarity Model;2023-09-04

3. A novel, accurate, and non-invasive liquid biopsy test to measure cellular immune responses as a tool to diagnose early-stage lung cancer: a clinical trials study;Respiratory Research;2023-02-14

4. In-silico study of influence of HLA heterogeneity on CTL responses across ethnicities to SARS-CoV-2;Human Immunology;2022-12

5. Model to predict on‐treatment restoration of functional HBV ‐specific CD8 ⁺ cell response foresees off‐treatment HBV control in eAg ‐negative chronic hepatitis B;Alimentary Pharmacology & Therapeutics;2022-02-27